Companies: 10,795·Total market cap: $144.5T
Janux Therapeutics, Inc.

Janux Therapeutics, Inc.

JANXNASDAQHealthcare● Active
$13.51
+$0.15(+1.12%)
Market Cap$823898623
P/E Ratio
52W High$35.34
52W Low$12.12
Overview

Janux Therapeutics, Inc. (JANX) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · JANX · as of Feb 26, 2026

Latest filing snapshot

109
+28+34.57%vs prior year

Janux Therapeutics, Inc. (JANX) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
109
Change (1Y)
+28
Growth % (1Y)
+34.57%
Revenue / Employee
$91.7K
Net Income / Employee
$-1.04M
Market Cap
$824M

JANX Employee Count

2021 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-02-26109+28+34.57%
2025-02-2781+17+26.56%
2024-03-0864+4+6.67%
2023-03-1060+27+81.82%
2022-03-1833

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
AbCellera Biologics Inc.
ABCL
AbCellera Biologics Inc.
596
#2
Harmony Biosciences Holdings, Inc.
HRMY
Harmony Biosciences Holdings, Inc.
268
#3
Biohaven Ltd.
BHVN
Biohaven Ltd.
256
#4
Celldex Therapeutics, Inc.
CLDX
Celldex Therapeutics, Inc.
186
#5
Immunome, Inc.
IMNM
Immunome, Inc.
131
#6
Maze Therapeutics, Inc.
MAZE
Maze Therapeutics, Inc.
125
#7
Janux Therapeutics, Inc.
JANX
Janux Therapeutics, Inc.YOU
109
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · JANX peer comparison

About JANX employees

JANX Employees · Headcount

Janux Therapeutics, Inc. (JANX) employee data is sourced from the annual SEC 10-K filing. As of 2025, Janux Therapeutics, Inc. had 109 full-time employees globally. Full-time employees only. Global consolidated headcount.

Janux Therapeutics, Inc. employs 109 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $91,743, reflecting the company's operational efficiency.

Janux Therapeutics, Inc.'s workforce increased by 28 (34.57%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Janux Therapeutics, Inc.'s revenue per employee of $91,743 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

JANX Employees · 5 questions

As of the latest SEC 10-K filing (2025), Janux Therapeutics, Inc. had 109 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Janux Therapeutics, Inc. employee counthow many employees does Janux Therapeutics, Inc. haveJANX total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-26